Biologicals for the treatment of systemic lupus erythematosus: current status and emerging therapies
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Biologicals for the treatment of systemic lupus erythematosus: current status and emerging therapies
Authors
Keywords
-
Journal
Expert Review of Clinical Immunology
Volume 11, Issue 1, Pages 109-116
Publisher
Informa UK Limited
Online
2014-12-16
DOI
10.1586/1744666x.2015.994508
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Treat-to-target in systemic lupus erythematosus: recommendations from an international task force
- (2014) Ronald F van Vollenhoven et al. ANNALS OF THE RHEUMATIC DISEASES
- Molecular abnormalities of the B cell in systemic lupus erythematosus are candidates for functional inhibition treatments
- (2014) Stamatis-Nick C Liossis et al. EXPERT OPINION ON PHARMACOTHERAPY
- Glucocorticoids and irreversible damage in patients with systemic lupus erythematosus
- (2014) I. Ruiz-Arruza et al. RHEUMATOLOGY
- Efficacy and safety of epratuzumab in patients with moderate/severe active systemic lupus erythematosus: results from EMBLEM, a phase IIb, randomised, double-blind, placebo-controlled, multicentre study
- (2013) Daniel J Wallace et al. ANNALS OF THE RHEUMATIC DISEASES
- Is it time for biosimilars in autoimmune diseases?
- (2013) Maria-Jose Cuadrado et al. AUTOIMMUNITY REVIEWS
- B-cell-targeted therapies in systemic lupus erythematosus
- (2013) Vera Sau-Fong Chan et al. Cellular & Molecular Immunology
- Efficacy of Abatacept for Arthritis in Patients with an Overlap Syndrome between Rheumatoid Arthritis and Systemic Lupus Erythematosus
- (2013) Kei Ikeda et al. Clinical & Developmental Immunology
- Disease Control and Safety of Belimumab Plus Standard Therapy Over 7 Years in Patients with Systemic Lupus Erythematosus
- (2013) E. M. Ginzler et al. JOURNAL OF RHEUMATOLOGY
- Targeted therapies in systemic lupus erythematosus
- (2013) P Grech et al. LUPUS
- Belimumab for Systemic Lupus Erythematosus
- (2013) Bevra Hannahs Hahn NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of Abatacept in Lupus Nephritis: A Twelve-Month, Randomized, Double-Blind Study
- (2013) Richard Furie et al. Arthritis & Rheumatology
- B-cell-depleting Therapy in Systemic Lupus Erythematosus
- (2012) Manuel Ramos-Casals et al. AMERICAN JOURNAL OF MEDICINE
- Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study
- (2012) Brad H. Rovin et al. ARTHRITIS AND RHEUMATISM
- Long-term safety profile of belimumab plus standard therapy in patients with systemic lupus erythematosus
- (2012) Joan T. Merrill et al. ARTHRITIS AND RHEUMATISM
- Abatacept for lupus nephritis: Alternative definitions of complete response support conflicting conclusions
- (2012) David Wofsy et al. ARTHRITIS AND RHEUMATISM
- Abatacept in the treatment of lupus
- (2012) Alberta Y. Hoi et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Unmet medical needs in systemic lupus erythematosus
- (2012) Aisha Lateef et al. ARTHRITIS RESEARCH & THERAPY
- Atacicept in combination with MMF and corticosteroids in lupus nephritis: results of a prematurely terminated trial
- (2012) Ellen M Ginzler et al. ARTHRITIS RESEARCH & THERAPY
- Biologic Differences Between Various Inhibitors of the BLyS/BAFF Pathway: Should We Expect Differences Between Belimumab and Other Inhibitors in Development?
- (2012) William Stohl Current Rheumatology Reports
- A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
- (2011) Richard Furie et al. ARTHRITIS AND RHEUMATISM
- Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
- (2011) Sandra V Navarra et al. LANCET
- Assessment of flares in lupus patients enrolled in a phase II/III study of rituximab (EXPLORER)
- (2011) JT Merrill et al. LUPUS
- Systemic activation of the immune system induces aberrant BAFF and APRIL expression in B cells in patients with systemic lupus erythematosus
- (2009) Van Trung Chu et al. ARTHRITIS AND RHEUMATISM
- Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: The randomized, double-blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial
- (2009) Joan T. Merrill et al. ARTHRITIS AND RHEUMATISM
- The role of B lymphocyte stimulator (BLyS) in systemic lupus erythematosus
- (2009) Michael P. Cancro et al. JOURNAL OF CLINICAL INVESTIGATION
- Systemic Lupus Erythematosus in 6 Male Cocaine Users at Bellevue Hospital
- (2009) T. L. RIVERA et al. JOURNAL OF RHEUMATOLOGY
- Prednisone, Lupus Activity, and Permanent Organ Damage
- (2009) M. THAMER et al. JOURNAL OF RHEUMATOLOGY
- Results of a two-year followup study of patients with rheumatoid arthritis who received a combination of abatacept and methotrexate
- (2008) Joel M. Kremer et al. ARTHRITIS AND RHEUMATISM
- Systemic Lupus Erythematosus
- (2008) Anisur Rahman et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation